Drug Therapy Limited in Patients with Huntington’s Disease

被引：0
作者：
机构：
来源：
Drugs & Therapy Perspectives | 1999年 / 14卷 / 12期
关键词：
Clozapine; Atypical Antipsychotic; Selegiline; Riluzole; Tetrabenazine;
D O I：
10.2165/00042310-199914120-00002
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 7
页数：2
相关论文
共 50 条
[31]   Dopaminergic signaling and striatal neurodegeneration in Huntington's disease [J].
Tang, Tie-Shan ;
Chen, Xi ;
Liu, Jing ;
Bezprozvanny, Ilya .
JOURNAL OF NEUROSCIENCE, 2007, 27 (30) :7899-7910
[32]   Therapeutic interventions for symptomatic treatment in Huntington's disease [J].
Mestre, T. ;
Ferreira, J. ;
Coelho, M. M. ;
Rosa, M. ;
Sampaio, C. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (03)
[33]   Tetrabenazine versus placebo for chorea in huntington’s disease [J].
John C. Morgan ;
Kapil D. Sethi .
Current Neurology and Neuroscience Reports, 2006, 6 (4) :277-278
[34]   Case report: Clinical lycanthropy in Huntington's disease [J].
Medford, Nick ;
Sigala, Natasha .
FRONTIERS IN PSYCHIATRY, 2023, 14
[35]   Chorea Associated With Huntington's Disease: To Treat or Not to Treat? [J].
Jankovic, Joseph ;
Roos, Raymund A. C. .
MOVEMENT DISORDERS, 2014, 29 (11) :1414-1418
[36]   Molecular medicine: predicting and preventing Huntington’s disease [J].
Ferdinando Squitieri ;
Milena Cannella ;
Luigi Frati .
Neurological Sciences, 2008, 29 :205-207
[37]   Tetrabenazine treatment for Huntington's disease - Associated chorea [J].
Ondo, WG ;
Tintner, R ;
Thomas, M ;
Jankovic, J .
CLINICAL NEUROPHARMACOLOGY, 2002, 25 (06) :300-302
[38]   An overview of psychiatric symptoms in Huntington's disease. [J].
Anderson K.E. ;
Marder K.S. .
Current Psychiatry Reports, 2001, 3 (5) :379-388
[39]   Deutetrabenazine: A Review in Chorea Associated with Huntington's Disease [J].
Heo, Young-A ;
Scott, Lesley J. .
DRUGS, 2017, 77 (17) :1857-1864
[40]   Huntington's disease: A decade beyond gene discovery [J].
Penelope Hogarth .
Current Neurology and Neuroscience Reports, 2003, 3 (4) :279-284
12345